324 related articles for article (PubMed ID: 20180915)
1. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
2. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
[TBL] [Abstract][Full Text] [Related]
3. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
[TBL] [Abstract][Full Text] [Related]
4. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
8. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
9. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
12. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
[TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
14. Pacemaker or defibrillator surgery without interruption of anticoagulation.
Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation is unnecessary after biological aortic valve replacement.
Moinuddeen K; Quin J; Shaw R; Dewar M; Tellides G; Kopf G; Elefteriades J
Circulation; 1998 Nov; 98(19 Suppl):II95-8; discussion II98-9. PubMed ID: 9852888
[TBL] [Abstract][Full Text] [Related]
16. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
17. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
18. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
19. Impact of an inpatient anticoagulation management service on clinical outcomes.
Biscup-Horn PJ; Streiff MB; Ulbrich TR; Nesbit TW; Shermock KM
Ann Pharmacother; 2008 Jun; 42(6):777-82. PubMed ID: 18460587
[TBL] [Abstract][Full Text] [Related]
20. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
